NIVF vs CYH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

NIVF

29.3
AI Score
VS
NIVF Wins

CYH

45.2
AI Score

Investment Advisor Scores

NIVF

29score
Recommendation
EXTENDED

CYH

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF CYH Winner
Forward P/E 0.0132 17.6056 NIVF
PEG Ratio 0 2.3833 Tie
Revenue Growth 11.9% -9.8% NIVF
Earnings Growth 0.0% -75.6% NIVF
Tradestie Score 29.3/100 45.2/100 CYH
Profit Margin 209.0% 2.1% NIVF
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

NIVF 1M: +102.4% · 3M: +84.3% CYH 1M: +0.3% · 3M: -4.3%

Current Technical Phase

NIVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 60

RSI (14): 59.7 · Price: $1.06

CYH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $2.92

Fundamentals Snapshot

Metric NIVF CYH
Market Cap
Forward P/E 0.0 -5.6
Trailing P/E 0.0 1.6
Revenue (TTM)
Revenue Growth 0.1% -0.1%
Gross Margin 0.2% 0.4%
Operating Margin -3.5% 0.1%
EPS 328.32 1.81
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.